Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study

Details

• Alternative Title:
  Diabetol Metab Syndr
• Personal Author:
  Tapley, Jeffrey L. ; McGwin, Gerald ; Ashraf, Ambika P. ; MacLennan, Paul A. ; Callahan, Koula ; Searcey, Karen ; Witherspoon, C. Douglas ; Saaddine, Jinan ; Owsley, Cynthia
• Description:
  Background
  
  We examined the feasibility and efficacy of using a non-mydriatic camera to screen for diabetic retinopathy (DR) among youth with type 1 or type 2 diabetes seen in a pediatric endocrinology clinic serving Alabama, the state that has the highest diabetes rate in the United States.
  
  Methods
  
  236 youths with type 1 or type 2 diabetes were screened for DR using a non-mydriatic camera. Visual acuity was also assessed. A questionnaire asked parents about diabetes and eye care history.
  
  Results
  
  Mean duration since diabetes diagnosis was 5.5 years. 66 % reported receiving an eye examination within the previous year. 97.5 % had images that were gradable. DR was detected in 3.8 % of participants. 9.1 % were visually impaired.
  
  Conclusions
  
  Use of a non-mydriatic fundus camera is feasible and efficacious for DR screening in youth with diabetes. DR screening at routine endocrinology visits may be beneficial in managing youth with diabetes and preventing irreversible vision loss, particularly for those in regions where diabetes rates are high.
  
  
• Subjects:
  Diabetes Complications Diabetes Mellitus Diabetic Retinopathy Pediatrics Research Visual Acuity
• Source:
  Diabetol Metab Syndr. 7.
• Pubmed ID:
  26136849
• Pubmed Central ID:
  PMC4487844
• Document Type:
  Journal Article
• Volume:
  7
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:41c632910fe2f906b2983ffdbe7ae21a2937c576b21e45b7aec227344d14bfbc
• Download URL:
  https://stacks.cdc.gov/view/cdc/31953/cdc_31953_DS1.pdf
• File Type:
  [PDF - 403.23 KB ]